Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1499
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Anastasios Konstas,Leopold Schmetterer,Vital P. Costa,Gábor Holló,Andreas Katsanos,Philippe Denis,Luciano Quaranta,Murat Irkec,Miguel A. Castejón,Miguel A. Teus,Alan L. Robin
Expert Opinion on Drug Safety.2020;()1
[DOI]
2A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
Curt Hartleben,Juan Camilo Parra,Amy Batoosingh,Paula Bernstein,Margot Goodkin
Journal of Ophthalmology.2017;2017()1
[DOI]
3A Comparative Study on Fixed Dose Combination of Brimonidine 0.2% and Timolol 0.5% vs. Monotherapy Brimonidine or Timolol in Patients with Primary Open Angle Glaucoma
Ashapurna Borgohain,Soumyadeep Majumdar,Soumya Swarup Chatterjee
Journal of Evidence Based Medicine and Healthcare.2020;7(12)610
[DOI]
4A Comparative Study on Fixed Dose Combination of Brimonidine 0.2% and Timolol 0.5% vs. Monotherapy Brimonidine or Timolol in Patients with Primary Open Angle Glaucoma
Lisa V. Stottlemyer,Alan Polnariev
Journal of Evidence Based Medicine and Healthcare.2016;38(12)503
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal